PA
AUPH icon

Parallel Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Parallel Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Buy
623
+29
+5% +$463 ﹤0.01% 2924
2026
Q1 		$8.8K Hold
594
– – ﹤0.01% 2812
2025
Q4 		$9.47K Hold
594
– – ﹤0.01% 2631
2025
Q3 		$6.56K Buy
+594
New +$6.49K ﹤0.01% 2671
2025
Q2 		– Sell
-43
Closed -$346 – 3555
2025
Q1 		$346 Hold
43
– – ﹤0.01% 3302
2024
Q4 		$386 Buy
+43
New +$351 ﹤0.01% 3276
2024
Q1 		– Sell
-12
Closed -$108 – 3304
2023
Q4 		$108 Buy
+12
New +$99 ﹤0.01% 3225
2021
Q2 		– Sell
-2,150
Closed -$28K – 2926
2021
Q1 		$28K Sell
2,150
-2,000
-48% -$29K ﹤0.01% 1440
2020
Q4 		$57K Buy
4,150
+4,080
+5,829% +$59.4K ﹤0.01% 1045
2020
Q3 		$1K Buy
+70
New +$1.01K ﹤0.01% 2403
2019
Q4 		– Sell
-2,500
Closed -$13K – 2402
2019
Q3 		$13K Buy
2,500
+500
+25% +$3.03K ﹤0.01% 1551
2019
Q2 		$13K Hold
2,000
– – ﹤0.01% 1462
2019
Q1 		$13K Hold
2,000
– – ﹤0.01% 1392
2018
Q4 		$13K Buy
2,000
+1,000
+100% +$5.77K ﹤0.01% 1210
2018
Q3 		$7K Buy
1,000
+500
+100% +$2.81K ﹤0.01% 1559
2018
Q2 		$2K Sell
500
-1,500
-75% -$8.37K ﹤0.01% 1811
2018
Q1 		$10K Sell
2,000
-3,000
-60% -$16.1K ﹤0.01% 1249
2017
Q4 		$23K Buy
5,000
+3,000
+150% +$16.7K ﹤0.01% 962
2017
Q3 		$11K Sell
2,000
-3,000
-60% -$18.9K ﹤0.01% 1237
2017
Q2 		$32K Hold
5,000
– – 0.01% 827
2017
Q1 		$36K Buy
+5,000
New +$23.1K 0.01% 740

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NFG
Norris Financial Group Greenville, South Carolina $251M AUM 48.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Parallel Advisors's AUPH Position: Q2 2026 in Review

Parallel Advisors increased its Aurinia Pharmaceuticals (AUPH) stake by 4.9% in Q2 2026, buying an estimated $463 and bringing the position to 623 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Parallel Advisors first reported a position in AUPH in Q1 2017 and has held it in 21 quarters since. The position peaked at $57K in Q4 2020. 109 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Parallel Advisors held 623 shares of Aurinia Pharmaceuticals worth $10.6K as of Q2 2026.
  • Parallel Advisors bought 29 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $463.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2924 holding.
  • Parallel Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 21 quarters since.
  • Parallel Advisors's Aurinia Pharmaceuticals position peaked at $57K in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.